Percutaneous Absorption of Betamethasone-17-Benzoate

Authors

George R. Mikhail

Abstract

Percutaneous absorption of betamethasone-17-benzoate, a new topical corticosteroid, was sufficient enough to result in adrenocortical suppression in patients with psoriasis or atopic dermatitis when 0.025% of the steroid cream was applied under occlusion to 30% or more of the body surface, using 9 gm or more of the preparation. The adrenal function returned to normal within a short time after the cream was discontinued.

Recommended Citation

Mikhail, George R. (1970) "Percutaneous Absorption of Betamethasone-17-Benzoate," Henry Ford Hospital Medical Journal : Vol. 18 : No. 3 , 179-186.
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol18/iss3/4